AbbVie Reports Third-Quarter 2020 Financial Results

NORTH CHICAGO, Ill., Oct. 30, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) announced financial results for the third quarter ended September 30, 2020. “We continue to be very well positioned for the long-term. Results from key growth products – including Skyrizi, Rinvoq and Ubrelvy – continue…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.